Table 3.
Neonatal Morbidity in Women who Use Marijuana Compared to Non-Users
Neonatal Outcome (Unweighted Sample Size) |
Any Marijuana Use (N=48) |
No Marijuana Use (N= 1562) |
P value |
---|---|---|---|
Neonatal intensive care unit admission | 16.9 | 9.5 | 0.12 |
Preterm delivery (<37 weeks) | 17.3 | 9.0 | 0.07 |
Composite neonatal morbidity or death | 14.1 | 4.5 | 0.002 |
-Neonatal pulmonary morbidity | 7.5 | 3.7 | 0.14 |
-Necrotizing enterocolitis | 0.4 | 0.2 | 0.33 |
-Seizures | 0.3 | 0.08 | 0.28 |
-Retinopathy of prematurity | 0.6 | 0.6 | 0.95 |
-Neonatal infection morbidity | 9.8 | 2.4 | <.001 |
-Anemia requiring blood transfusion | 1.3 | 0.7 | 0.24 |
-Neonatal surgery | 0.3 | 0.8 | 0.37 |
-Hyperbilirubinemia | -0- | 0.03 | --- |
-Neonatal neurological morbidity | 1.4 | 0.3 | 0.002 |
-Neonatal death in L&D suite or prior to discharge | 0.4 | 0.3 | 0.63 |
Composite neonatal morbidity includes indented list presented in remaining rows of table.
All results are reported as weighted percentages, p-value from weighted chi-square. The composite neonatal morbidity endpoint was defined by “any yes” or “all no”, as such some item non-response is present for individual components.